Skip to content

REGENXBIO Inc.

RGNX Nasdaq SEC CIK 1590877

Follow REGENXBIO Weekly email: filings, results, news

News

8 stories filed under REGENXBIO

Markets

Thread · 4 stories

Regenxbio director Ciongoli buys $949,381 in RGNX stock

Markets 27 d ago

Regenxbio: Sell-Off On Hunter Setback Presents A Risky Buy Opportunity

Markets 30 d ago

STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns

Markets 31 d ago 2 sources

Why is Regenxbio stock plunging today?

Markets 31 d ago

More coverage

Regenxbio's Multi-Catalyst Setup Is Hard To Ignore (Rating Upgrade)

Markets 44 d ago

H.C. Wainwright lowers Regenxbio stock price target on equity offering

Markets 45 d ago

Barclays downgrades Regenxbio stock rating on regulatory concerns

Policy 48 d ago also on BCS

REGENXBIO Inc. (RGNX) Q2 2026 Earnings Call Transcript

Earnings 49 d ago

Next results

NOV5

Q3 2026 results

Thursday · estimated from the filing cadence

Profile

Headquarters: ROCKVILLE, MD, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 8 stories clustered from the RSS aggregator